Accéder au contenu
Merck

[Effect of mefenamic acid and sodium salicylate on lymphocyte transformation due to phytohemagglutinin].

Farmakologiia i toksikologiia (1980-03-01)
I V Petrova, G M Aleksandrova
RÉSUMÉ

It is established in in-vitro experiments that mefenamic acid and sodium salicylate inhibit to an equal measure the cell immunity test, a reaction of blast transformation of lymphocytes. The effect increases with the higher concentration of the drugs under study and depends on the time they are introduced into the culture with respect to the introduction of the non-specific mitotic stimulant phytohemagglutinin.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Salicylate de sodium, ReagentPlus®, ≥99.5% (titration)
Sigma-Aldrich
Salicylate de sodium, 98.0-102.0% anhydrous basis, meets USP testing specifications
Sigma-Aldrich
Mefenamic acid
Sigma-Aldrich
Salicylate de sodium, ≥99.5% (HPLC), puriss. p.a.
Sigma-Aldrich
Salicylate de sodium, puriss. p.a., reag. Ph. Eur., 99.5-101.0% (calc. to the dried substance)
Supelco
Mefenamic acid, analytical standard
Mefenamic acid, European Pharmacopoeia (EP) Reference Standard
Salicylate de sodium, European Pharmacopoeia (EP) Reference Standard